Browse > Article

Dose Verification Study of Brachytherapy Plans Using Monte Carlo Methods and CT Images  

Cheong, Kwang-Ho (Department of Radiation Oncology, Hallym University College of Medicine)
Lee, Me-Yeon (Department of Radiation Oncology, Hallym University College of Medicine)
Kang, Sei-Kwon (Department of Radiation Oncology, Hallym University College of Medicine)
Bae, Hoon-Sik (Department of Radiation Oncology, Hallym University College of Medicine)
Park, So-Ah (Department of Radiation Oncology, Hallym University College of Medicine)
Kim, Kyoung-Joo (Department of Radiation Oncology, Hallym University College of Medicine)
Hwang, Tae-Jin (Department of Radiation Oncology, Hallym University College of Medicine)
Oh, Do-Hoon (Department of Radiation Oncology, Hallym University College of Medicine)
Publication Information
Progress in Medical Physics / v.21, no.3, 2010 , pp. 253-260 More about this Journal
Abstract
Most brachytherapy treatment planning systems employ a dosimetry formalism based on the AAPM TG-43 report which does not appropriately consider tissue heterogeneity. In this study we aimed to set up a simple Monte Carlo-based intracavitary high-dose-rate brachytherapy (IC-HDRB) plan verification platform, focusing particularly on the robustness of the direct Monte Carlo dose calculation using material and density information derived from CT images. CT images of slab phantoms and a uterine cervical cancer patient were used for brachytherapy plans based on the Plato (Nucletron, Netherlands) brachytherapy planning system. Monte Carlo simulations were implemented using the parameters from the Plato system and compared with the EBT film dosimetry and conventional dose computations. EGSnrc based DOSXYZnrc code was used for Monte Carlo simulations. Each $^{192}Ir$ source of the afterloader was approximately modeled as a parallel-piped shape inside the converted CT data set whose voxel size was $2{\times}2{\times}2\;mm^3$. Bracytherapy dose calculations based on the TG-43 showed good agreement with the Monte Carlo results in a homogeneous media whose density was close to water, but there were significant errors in high-density materials. For a patient case, A and B point dose differences were less than 3%, while the mean dose discrepancy was as much as 5%. Conventional dose computation methods might underdose the targets by not accounting for the effects of high-density materials. The proposed platform was shown to be feasible and to have good dose calculation accuracy. One should be careful when confirming the plan using a conventional brachytherapy dose computation method, and moreover, an independent dose verification system as developed in this study might be helpful.
Keywords
Monte Carlo; DOSXYZnrc; AAPM TG-43; Brachytherapy; $^{192}Ir$;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Karaiskos P, Angelopoulos A, Sakelliou L, et al: Monte carlo and TLD dosimetry of an 192Ir high dose-rate brachytherapy source. Med Phys 25:1975-1984 (1998)   DOI   ScienceOn
2 Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS: Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM radiation therapy committee task group no. 43. american association of physicists in medicine. Med Phys 22:209-234 (1995)   DOI   ScienceOn
3 Tedgren AK, Ahnesjo A: Accounting for high Z shields in brachytherapy using collapsed cone superposition for scatter dose calculation. Med Phys 30:2206-2217 (2003)   DOI   ScienceOn
4 Chibani O, Williamson JF: MCPI: A sub-minute monte carlo dose calculation engine for prostate implants. Med Phys 32:3688-3698 (2005)   DOI   ScienceOn
5 Rivard MJ, Coursey BM, DeWerd LA, et al: Update of AAPM task group no. 43 report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys 31:633-674 (2004)   DOI   ScienceOn
6 Poon E, Williamson JF, Vuong T, Verhaegen F: Patientspecific monte carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator. Int J Radiat Oncol Biol Phys 72:1259-1266 (2008)   DOI   ScienceOn
7 Meigooni AS, Kleiman MT, Johnson JL, Mazloomdoost D, Ibbott GS: Dosimetric characteristics of a new high-intensity 192Ir source for remote afterloading. Med Phys 24:2008-2013 (1997)   DOI   ScienceOn
8 Melhus CS, Rivard MJ: Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources. Med Phys 33:1729-1737 (2006)
9 Daskalov GM, Kirov AS, Williamson JF: Analytical approach to heterogeneity correction factor calculation for brachytherapy. Med Phys 25:722-735 (1998)   DOI   ScienceOn
10 Anagnostopoulos G, Baltas D, Karaiskos P, Pantelis E, Papagiannis P, Sakelliou L: An analytical dosimetry model as a step towards accounting for inhomogeneities and bounded geometries in 192Ir brachytherapy treatment planning. Phys Med Biol 48:1625-1647 (2003)   DOI   ScienceOn
11 Li Z, Williamson JF: Volume-based geometric modeling for radiation transport calculations. Med Phys 19:667-677 (1992)   DOI   ScienceOn
12 Taylor RE, Yegin G, Rogers DW: Benchmarking brachydose: Voxel based EGSnrc monte carlo calculations of TG-43 dosimetry parameters. Med Phys 34:445-457 (2007)   DOI   ScienceOn
13 Poon E, Verhaegen F: A CT-based analytical dose calculation method for HDR 192Ir brachytherapy. Med Phys 36:3982-3994 (2009)   DOI   ScienceOn
14 Walters B, Kawrakow I, Rogers DWO: DOSXYZnrc users manual. NRCC Report PIRS-794revB, Ottawa, Canada (2009)
15 Angelopoulos A, Baras P, Sakelliou L, Karaiskos P, Sandilos P: Monte carlo dosimetry of a new 192Ir high dose rate brachytherapy source. Med Phys 27:2521-2527 (2000)   DOI   ScienceOn
16 Daskalov GM, Baker RS, Rogers DW, Williamson JF:Dosimetric modeling of the microselectron high-dose rate 192Ir source by the multigroup discrete ordinates method. Med Phys 27:2307-2319 (2000)   DOI   ScienceOn
17 ICRU Report 38: Dose and volume specifications for reporting intracavitary therapy in gynecology. International Commission on Radiation Units and Measurements, Bethesda, MD (1985)
18 Shin KH, Kim TH, Cho JK, et al: CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters. Int J Radiat Oncol Biol Phys 64:197-204 (2006)   DOI   ScienceOn